B4244 - Genetics of neurodevelopmental traits and disorders in ALSPAC - 15/05/2023

B number: 
B4244
Principal applicant name: 
Hilary Martin | Wellcome Sanger Institute, UK (UK)
Co-applicants: 
Dr. Varun Warrier, Prof. Stephan Sanders, Prof. Michael Talkowski, Dr. Mahmoud Koko Musa, Dr. Ruth Eberhardt, Dr. Kyle Satterstrom, Dr. Shan Dong, Dr. Jack Fu, Dr. Stephanie Hao, Yuanjun Gu
Title of project: 
Genetics of neurodevelopmental traits and disorders in ALSPAC
Proposal summary: 

This project will look at the genetic underpinnings of neurodevelopmental traits such as cognitive ability and social and communication difficulties, and the genetics of related conditions such as autism, intellectual disability and ADHD. It is known that both common and rare genetic variants influence these traits. In this project, we will use the extensive longitudinal data in ALSPAC to construct trajectories of neurodevelopmental traits over time, and look at genetic influences on these and whether they are moderated by environmental factors. We will also contribute data to the Autism Sequencing Consortium (ASC), a leading international collaborative group working on deciphering autism genetics and its relation to cognition and brain development. We plan to combine ALSPAC clinical and sequencing data with other datasets of similar nature from the ASC, to identify new genes underlying autism, understand genetic differences between autistic individuals who have different co-morbidities and understand sex differences in autism.

Impact of research: 
Our research will lead to a greater understanding of how different types of genetic and environmental factors affect neurodevelopment and its relation to autism. It will increase our understanding of the relationship between rare genetic variants and autistic traits, helping decipher the elusive mechanisms of observed sex differences in autism.
Date proposal received: 
Thursday, 26 January, 2023
Date proposal approved: 
Monday, 30 January, 2023
Keywords: 
Genetic epidemiology (including association studies and mendelian randomisation), Behaviour - e.g. antisocial behaviour, risk behaviour, etc., Developmental disorders - autism, Cognitive impairment, Congenital abnormalities, Epilepsy, Learning difficulty, Mental health, Speech/language problem, DNA sequencing, GWAS, Statistical methods, Childhood - childcare, childhood adversity, Cognition - cognitive function, Speech and language, Communication (including non-verbal), Development, Genetic epidemiology, Genetics, Genomics, Genome wide association study, Neurology, Sex differences